CAESAREA, Israel, Oct. 6, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced the addition...
By connecting information about each person's health, care and coverage, Health Sense℠ helps people receive continuous personalized support, make informed decisions and act sooner Projected to reduce inefficient health care spending by 10% by 2030, improving affordability for employers...
SHARx's Rising Tides brings together respected athletes and leaders to inspire a grassroots movement for prescription access and affordability into helping patients, families and employers see that longstanding barriers are not movable. ST. LOUIS, Oct. 6, 2026 /PRNewswire/ -- Sophie...
Brown Girls' Disease? A Guide to Sexual Health and Empowerment Through a South Asian Lens challenges patients and clinicians to rethink how women's pain, sexuality and health concerns are understood CHICAGO, Oct. 6, 2026 /PRNewswire/ -- What happens when a woman knows something is wrong,...
Voice4PIMD analyzes an individual's expressions, gestures, eye gaze, and other nonverbal cues—and translates them into information caregivers can understand. NOTRE DAME, Ind., Oct. 6, 2026 /PRNewswire/ -- Haley Hilt may not speak, but her grandfather, Ed Fennell, will tell you she says...
Strategic Acquisition Enhances Pharmacy Diversification into Underserved Market, Supporting the Launch of New High-Value, High Margin Healthcare Services for Regional Providers and Patients HALLANDALE BEACH, Fla., Oct. 6, 2026 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL) ("NextPlat" or...
– Series B financing led by Alta Partners with participation from Series A co-leads Venrock and Foresite Capital, new investor J. Wood Capital and others – – K-1728 is designed to selectively inhibit both kinase domain and helical domain PI3Kα mutations while sparing wild-type PI3Kα – –...
TALLAHASSEE, Fla., Oct. 6, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., will hold a conference call on Thursday, November 5, 2026 at 8:30 AM Eastern Time following the release of...
INDIANAPOLIS, Oct. 6, 2026 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it will release its third quarter 2026 earnings on Wednesday, November 11, 2026, after the stock market close via press release and its website. The earnings will be presented in a live webcast on...
KÖLN, Deutschland, 6. Oktober 2026 /PRNewswire/ -- Cellex Cell Professionals hat die Marke von 10.000 autologen Produktionschargen für Arzneimittel für neuartige Therapien (ATMPs) überschritten, die für 12 klinische und kommerzielle Partnerprogramme hergestellt wurden. Dieser Meilenstein...